Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueReturn on AssetsReturn on Sales

Mainz Biomed (MYNZ) EBT Margin (2022 - 2023)

Historic EBT Margin for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to 2413.53%.

  • Mainz Biomed's EBT Margin rose 18231300.0% to 2413.53% in Q4 2023 from the same period last year, while for Dec 2023 it was 2936.5%, marking a year-over-year increase of 20434000.0%. This contributed to the annual value of 2421.8% for FY2024, which is 5147000.0% up from last year.
  • As of Q4 2023, Mainz Biomed's EBT Margin stood at 2413.53%, which was up 18231300.0% from 3467.71% recorded in Q3 2023.
  • Mainz Biomed's 5-year EBT Margin high stood at 2413.53% for Q4 2023, and its period low was 5781.76% during Q3 2022.